TransMHCII: a novel MHC-II binding prediction model built using a protein language model and an image classifier

Xin Yu1, Christopher Negron1, Lili Huang1

  • 1Biotherapeutics Discovery, AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA.

Antibody Therapeutics
|June 21, 2023
PubMed
Summary

We developed TransMHCII, a novel deep learning model using protein language models and image classifiers to predict major histocompatibility complex class II (MHC-II) binding affinity, outperforming existing methods.